STAA - STAAR SURGICAL CO

18.46
-0.110   -0.596%

Share volume: 813,885
Last Updated: 03-06-2026
Medical Equipment/Ophthalmic Goods: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$18.57
-0.11
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
48%
Profitability 25%
Dept financing 50%
Liquidity 75%
Performance 64%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.10%
1 Month
6.03%
3 Months
-21.58%
6 Months
-33.33%
1 Year
0.65%
2 Year
-47.42%
Key data
Stock price
$18.46
P/E Ratio 
N/A
DAY RANGE
$17.97 - $18.54
EPS 
-$1.95
52 WEEK RANGE
$14.69 - $30.81
52 WEEK CHANGE
-$6.06
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
49.513 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
0.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,549,444
AVERAGE 30 VOLUME 
$1,522,390
Company detail
CEO: Caren L. Mason
Region: US
Website: staar.com
Employees: 960
IPO year: 1992
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable lenses for the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems.

Recent news